Second, pretreatment with the sEH inhibitor TPPU [1-(1-propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy) phenyl) urea] prevented the onset of depression-like behaviors after CSDS. This evidence concerns the gene EPHX2 and depressive symptom measurement.